Are you suffering from Alzheimer's disease?
Alzheimer's disease is a degenerative disorder that affects the brain and causes dementia (cognitive and intellectual deterioration), especially late in life. It was named for Alois Alzheimer (1864-1915), a German neurologist who described it in 1907.
However, I believe that Alzheimer's disease existed in different description since the time of human race came to this world. The disease does not mean only for old aged people but all ages from young to old.
Symptoms of Alzheimer's disease varies widely and some may not be noticeable especially for young children especially teens. Although Alzheimer's disease is not a normal part of the aging process, the risk of developing the disease increases as people grow older.
Alzheimer's disease takes a devastating toll, not only on the patients, but also on those who love and care for them. Some patients experience immense fear and frustration as they struggle with once commonplace tasks and slowly lose their independence. Family, friends, and especially those who provide daily care suffer immeasurable pain and stress as they witness Alzheimer's disease slowly take their loved one from them.
The onset of Alzheimer's disease is usually very gradual. In the early stages, Alzheimer's patients have relatively mild problems learning new information and remembering where they have left common objects, such as keys or a wallet. In time, they begin to have trouble recollecting recent events and finding the right words to express themselves. As the disease progresses, patients may have difficulty remembering what day or month it is, or finding their way around familiar surroundings. They may develop a tendency to wander off and then be unable to find their way back. Patients often become irritable or withdrawn as they struggle with fear and frustration when once commonplace tasks become unfamiliar and intimidating. Behavioral changes may become more pronounced as patients become paranoid or delusional and unable to engage in normal conversation.
Doctors and scientists claim that brains of patients with Alzheimer's have distinctive formations, abnormally shaped proteins called tangles and plaques that are recognized as the hallmark of the disease, and these are related to memory. Tangles are long, slender tendrils found inside nerve cells, or neurons. Scientists have learned that when a protein called tau becomes altered, it may cause the characteristic tangles in the brain of an Alzheimer's patient.
In healthy brains, tau provides structural support for neurons, but in Alzheimer's patients this structural support collapses.
According to my study, it is not true. These distinctive formations of proteins are the byproducts caused by energy force of the electric static therapy from outer surface of the body. It is also not true according my research that people with a family history of Alzheimer's disease are more likely to develop Alzheimer's disease.
The causes of Alzheimer's disease remain a mystery among doctors and scientists of the world. According to doctors, Alzheimer's disease is only positively diagnosed by examining brain tissue under a microscope to see the hallmark plaques and tangles and this is only possible after a patient dies.
Isn't this a crazy way of diagnosis? As I mentioned previously, the hallmark plaques and tangles are the byproducts caused by the disease. Why can you not prevent to have such byproducts before you suffer from the disease? As a result, physicians rely on a series of other techniques to diagnose probable Alzheimer's disease in living patients. The physician also asks about the patient's family medical history to learn about any past serious illnesses, which may give a clue about the patient's current symptoms. As I mentioned, it is caused by the electric static therapy waves.
According to physicians I know, there is no known cure for Alzheimer's disease, and treatment focuses on lessening symptoms and attempting to slow the course of the disease. Drugs that increase or improve the function of brain acetylcholine, the neurotransmitter that affects memory, have been approved by the United States Food and Drug Administration (FDA) for the treatment of Alzheimer's disease.
Called acetylcholinesterase inhibitors, these drugs have had modest but clearly positive effects on the symptoms of the disease. These drugs can benefit patients at all stages of illness, but they are particularly effective in the middle stage.
This finding corresponds with new evidence that low acetylcholine levels in patients with Alzheimer's disease may not be present in the earliest stage of the illness. Evidence shows that there is inflammation in the brains of Alzheimer's patients, which may be associated with the production of amyloid precursor protein. Studies are still underway by scientists of the world.